Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

CAPTOPRIL Drug Profile

« Back to Dashboard

What is the patent landscape for Captopril, and what generic Captopril alternatives are available?

Captopril is a drug marketed by Hikma Intl Pharms, Vintage Pharms Llc, Sandoz, Teva, Dava Pharms Inc, Wockhardt, G And W Labs Inc, Mylan Pharms Inc, Apotex, Purepac Pharm, Egis Pharms, Watson Labs, Apothecon, Prinston Inc, Stason, Par Pharm, Ivax Sub Teva Pharms, and Mylan. and is included in twenty-eight NDAs.

The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.

Summary for Tradename: CAPTOPRIL

Patents:0
Applicants:18
NDAs:28
Suppliers / Packagers: see list30
Bulk Api Vendors: see list58
Clinical Trials: see list12
Patent Applications: see list8,320
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CAPTOPRIL at DailyMed

Pharmacology for Tradename: CAPTOPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stason
CAPTOPRIL
captopril
TABLET;ORAL074677-003May 30, 1997DISCNNoNo► Subscribe► Subscribe
Ivax Sub Teva Pharms
CAPTOPRIL AND HYDROCHLOROTHIAZIDE
captopril; hydrochlorothiazide
TABLET;ORAL075055-003Jun 18, 1998DISCNNoNo► Subscribe► Subscribe
Egis Pharms
CAPTOPRIL
captopril
TABLET;ORAL074748-004May 29, 1997DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
CAPTOPRIL
captopril
TABLET;ORAL074434-004Feb 13, 1996ABRXNoYes► Subscribe► Subscribe
G And W Labs Inc
CAPTOPRIL
captopril
TABLET;ORAL074590-002Aug 30, 1996DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot